Cjc 1295 Ipamorelin vs IGF-1 LR3: Literature and Handling Compared
Cjc 1295 Ipamorelin and IGF-1 LR3 are routinely cross-referenced by researchers scoping a literature review. The two records are not equivalent.
Compound profiles
Cjc 1295 Ipamorelin in the indexed record
The literature on Cjc 1295 Ipamorelin is a limited body of work: 10 PubMed-indexed records with no registered studies currently listed on ClinicalTrials.gov.
Journals represented in the current index include Am J Sports Med, Int J Mol Sci, J Am Acad Orthop Surg Glob Res Rev.
- Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians — Am J Sports Med, 2026. PMID: 41476424
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions — J Am Acad Orthop Surg Glob Res Rev, 2026. PMID: 41490200
- Peptide Supplements and Their Therapeutic Applications in Sports Medicine — Am J Sports Med, 2026. PMID: 42578445
- Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives — Int J Mol Sci, 2026. PMID: 42123471
IGF-1 LR3 in the indexed record
IGF-1 LR3 returns 11 indexed records on PubMed, a limited record with no registered studies currently listed on ClinicalTrials.gov.
Publications carrying this compound include Am J Physiol Endocrinol Metab, Appl Microbiol Biotechnol, FASEB J, spanning 2020–2025.
- Recombinant expression of IGF-1 and LR3 IGF-1 fused with xylanase in Pichia pastoris — Appl Microbiol Biotechnol, 2023. PMID: 37261455
- IGF-1 LR3 does not promote growth in late-gestation growth-restricted fetal sheep — Am J Physiol Endocrinol Metab, 2025. PMID: 39679943
- Attenuated glucose-stimulated insulin secretion during an acute IGF-1 LR3 infusion into fetal sheep does not persist in isolated islets — J Dev Orig Health Dis, 2023. PMID: 37114757
- Revolutionary decellularized Alstroemeria stem-based nerve conduit integrated with GelMA and controlled IGF-1 LR3 release for enhanced rat sciatic nerve regeneration — Int J Biol Macromol, 2025. PMID: 41015370
How the literature differs
The indexed record is not symmetrical between these two compounds. IGF-1 LR3 carries 1 more indexed records than Cjc 1295 Ipamorelin, which means published methodology, characterisation data and replication attempts are more readily located for IGF-1 LR3. For a researcher planning a literature review, that asymmetry usually determines which compound has established reference protocols and which requires primary-source work.
Registered study counts (0 vs 0) track a different signal — formal study registration rather than published output — and the two figures frequently diverge.
Side-by-side research profile
| Parameter | Cjc 1295 Ipamorelin | IGF-1 LR3 |
|---|---|---|
| PubMed indexed records | 10 | 11 |
| Registered studies (ClinicalTrials.gov) | 0 | 0 |
| Literature depth | Emerging | Emerging |
| Handling class | Lyophilised powder | Lyophilised powder |
| Designation | Research use only | Research use only |
Classification and why it matters
Cjc 1295 Ipamorelin and IGF-1 LR3 sit in different structural classes, and that classification is what determines whether a published protocol for one has any bearing on the other. Peptide research compounds are grouped by sequence length, origin and the receptor families the literature associates with them — not by the outcome a reader might be looking for.
Reading across classes is the most common error in a literature review. A protocol developed for Cjc 1295 Ipamorelin describes conditions validated for Cjc 1295 Ipamorelin: concentration ranges, solvent choice, incubation windows and control selection were all established against that compound. Applying those same conditions to IGF-1 LR3 without re-validation produces data that cannot be compared back to the source publication.
Where the two compounds are studied in overlapping models, the published work almost always treats them as separate arms rather than as substitutes. That separation is the useful signal: it indicates the research record does not consider them equivalent.
Selecting between them for a study design
Cjc 1295 Ipamorelin and IGF-1 LR3 are not interchangeable. They differ in structural class and in the pathways the literature associates with each, so substituting one for the other changes what a model is actually measuring.
Where a protocol cites a specific compound, the cited compound is the one the published result applies to. Where no protocol exists, the compound with the deeper indexed record (IGF-1 LR3) generally offers more methodological precedent.
Physical handling notes
Both arrive lyophilised. Standard practice keeps the unopened vial at -20°C, protected from light, and defers reconstitution until the point of use. Solution-phase stability is the limiting factor in most protocols, not powder-phase stability.
Repeated freezing and thawing is the most common avoidable source of degradation.
Verification and documentation
What is in the vial is established by lot-specific analytics, not by label text. HPLC gives purity as a share of total peak area; mass spectrometry confirms the molecular weight matches the intended sequence. Neither substitutes for the other.
Frequently asked questions
Which of Cjc 1295 Ipamorelin or IGF-1 LR3 has more published research?
IGF-1 LR3, with 11 indexed PubMed records against 10.
Are Cjc 1295 Ipamorelin and IGF-1 LR3 the same compound?
No. They are structurally distinct research compounds with separate literature records — 10 indexed records for Cjc 1295 Ipamorelin and 11 for IGF-1 LR3.
How should these compounds be stored?
Lyophilised material is conventionally stored at -20°C protected from light. Reconstituted solution is far less stable and is held at 2-8°C for short-duration laboratory work only.
Related references
- IGF-1 LR3 — product and lot documentation
- Certificate of analysis & purity testing
- Research reference index
Research use only. The compounds discussed are supplied for in-vitro laboratory research. They are not drugs, are not approved for the diagnosis, treatment, cure or prevention of any condition, and are not intended for human or veterinary consumption.